Horizon Healthcare Services Invests in Oncology Management Technology with Counsel from Corporate Group
Horizon Healthcare Services, Inc. (Horizon) invested in COTA, Inc., an oncology management technology company based in Hackensack, NJ. COTA's real-time data platform assists physicians with providing personalized and optimal care to cancer patients as well as enabling practices and health plans to move to value-based care models that reward the quality, not quantity, of care cancer patients receive.
“Horizon’s goal is to assist doctors in providing their patients with the most effective and efficient treatment possible, and COTA has the potential to become a powerful tool to help them do that,” said Glenn D. Pomerantz, MD, JD, Vice President and Chief Medical Officer of Horizon BCBSNJ. “In the molecular age of medicine, the data COTA provides can give doctors a clearer picture of how to most effectively treat their patients, so we see this as an investment to further transform how health plans and doctors collaborate to improve safety and patient outcomes.”
Horizon was represented in the transaction by Lori Smith, Ryan Udell and Josh Galante.